Callan JMB Inc (CJMB)

Form 8-K - Current report

Callan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization

Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in...

Form EFFECT - Notice of Effectiveness

Form 4 - Statement of changes in beneficial ownership of securities

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement

Strategic extension reinforces recurring revenue visibility and growing demand for preparedness, continuity...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure

Completion of a Partnership Agreement with Walker’s Pharmaceuticals of India Establishes First On-Site...

Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC

Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the...

Form 8-K - Current report

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update

The Company Deepened its Government Relationships at Both State and Federal Levels, Particularly to Support...